Introduction Sepsis biomarkers can have important diagnostic, therapeutic, and prognostic
functions. In a previous review, we identified 3370 references reporting on 178 different …

Sepsis is a major source of mortality and morbidity globally. Accurately diagnosing sepsis
remains challenging due to the heterogeneous nature of the disease, and delays in …

Background Sepsis can be detected in an early stage in the emergency department (ED) by
biomarkers and clinical scoring systems. A combination of multiple biomarkers or biomarker …

Objective. Using biomarkers for early and accurate identification of patients at low risk of
serious illness may improve the flow in the emergency department (ED) by classifying these …

Introduction Soluble urokinase plasminogen activator receptor (suPAR) is a prognostic and
nonspecific biomarker associated with short-term mortality in emergency department (ED) …

Introduction Identifying patients at high risk of developing kidney disease could lead to early
clinical interventions that prevent or slow disease progression. Soluble urokinase …

Background: The biomarker soluble urokinase plasminogen activator receptor (suPAR) is an
indicator of inflammation which is increased in a variety of chronic and acute disease states …

Aim: The purpose of this review is to summarize all relevant publications regarding the use
and validity of the soluble urokinase plasminogen activator receptor (suPAR) when used by …

Background Older patients is a complex group at increased risk of adverse outcomes
compared to younger patients, which should be considered in the risk assessment …

Aim To evaluate the effect of four different drug classes on soluble urokinase plasminogen
activator receptor (suPAR), a biomarker active in multiple inflammatory processes and a risk …